November 11, 2020
According to the report titled ‘Global Contrast Media Injectors Market Size study, by Type (Single Head Injectors, Dual Head Injectors, Syringeless Injectors), by Product (Injector Systems, Consumables), by Application (Radiology, Interventional Cardiology, Interventional Radiology), by End-Use (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers (ASCs)) and Regional Forecasts 2020-2027’, available with Market Study Report, global contrast media injectors market was valued at USD 1.2 billion in 2019 and is expected to grow with a CAGR of 7.4% during 2020-2027.
Increasing investment & government funding towards product development, growing approvals of contrast agents, and rising pervasiveness of chronic disorders like cardiovascular diseases and cancer are the key factors driving the growth of global contrast media injectors market.
Notably, in order to enhance the range of tissues for medical imaging procedures, contrast media injectors (CMI) are used to inject contrast agents into the human body. Several advances such as automated data assortment for dose intake as well as modules for minimized contrast agent wastage are making the product cost-effective, hence impelling the market outlook.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2895872/
Not only does automated injector system accurately manage the amount of contrast waste, but it also provides patients with personalized doses by accessing data from Picture Archiving & Communication System (PACS) or Electronic Medical Record (EMR). Furthermore, contrast dose recording software offers new potential for radiology departments to streamline contrast media usage, which is likely to stimulate global contrast media injectors market expansion over the estimated timeframe.
However, unfavorable outcomes of contrast agents and hefty cost of contrast media injectors & accessories are anticipated to hamper the industry landscape over the study period.
Citing the geographical terrain, worldwide contrast media injectors market sphere is segmented into North America, Asia Pacific, Latin America, Europe, and Rest of the World. The report claims that North America currently accounts for a considerable market share and is anticipated to grow further over the analysis period, owing to concentration of major players and surging demand for minimally invasive procedures.
Meanwhile, Asia Pacific contrast media injectors industry size is slated to grow substantially through 2027, on account of enhancing healthcare infrastructure in developing economies such as India and China, along with rising pervasiveness of cardiovascular diseases and cancer.